Lyme disease vaccine - Antigenics
Latest Information Update: 19 Aug 1999
At a glance
- Originator Antigenics
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Lyme disease
Most Recent Events
- 19 Aug 1999 New profile, split from generic Lyme disease vaccine profile
- 19 Aug 1999 Discontinued-Preclinical for Lyme disease in USA (Unknown route)